Response to Carfilzomib based therapy in patients with multiple myeloma progressing on Bortezomib based therapy

Trial Profile

Response to Carfilzomib based therapy in patients with multiple myeloma progressing on Bortezomib based therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2017

At a glance

  • Drugs Carfilzomib (Primary) ; Bortezomib
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jul 2017 New trial record
    • 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top